High-throughput mutation profiling changes before and 3 weeks after chemotherapy in newly diagnosed breast cancer patients
10.1371/journal.pone.0142466
Saved in:
Main Authors: | Tan S.-H., Sabrina Sapari N., Miao H., Hartman M., Loh M., Chng W.-J., Iau P., Ahmad Buhari S., Soong R., Lee S.-C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/142605 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors
by: Choo, Joan RE, et al.
Published: (2023) -
Prevalence of Gestational Diabetes Diagnosed before 24 Weeks of Gestation
by: Prasit K.
Published: (2023) -
Incidence of gestational diabetes mellitus diagnosed before 20 weeks of gestation
by: Dittakarn Boriboonhirunsarn, et al.
Published: (2018) -
TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
by: Pimjai Niparuck, et al.
Published: (2022) -
Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients
by: Elisna Syahruddin, -, et al.
Published: (2018)